Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.
Dan Riskin
Advertisement
Articles by Dan Riskin
Applied Clinical Trials
The FDA has been working to enable greater adoption of RWE in clinical and regulatory decisions, as mandated by the 21st Century Cures Act.
Advertisement
Latest Updated Articles
- How to Transition RWE Studies from Non-Clinical to Regulatory-Grade
January 10th 2019
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why So Many Patients From Underrepresented Groups Are Never Asked to Join a Trial
2
Why APAC Clinical Trial Sites Deserve a Second Look: Q&A with James Cheong, Precision for Medicine
3
Continuous Glucose Monitoring in Diabetes Clinical Trials: Endpoints, Regulatory Guidance, and Operational Best Practices
4
FDA Reportedly Pauses Commissioner’s National Priority Voucher Pilot as Existing Reviews Continue
5